Home » Roche’s Cancer Drug T-DM1 Shows Promise in Study
Roche’s Cancer Drug T-DM1 Shows Promise in Study
Roche Holding AG’s experimental cancer drug T-DM1 is more effective than older therapies, with substantially fewer side-effects in breast cancer, giving the Swiss drugmaker’s pipeline a much needed boost.
CNBC
CNBC
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May